Filter Results:
(4,690)
Show Results For
- All HBS Web
(4,690)
- People (16)
- News (1,872)
- Research (2,251)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,837)
Show Results For
- All HBS Web
(4,690)
- People (16)
- News (1,872)
- Research (2,251)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,837)
- December 1986 (Revised November 1988)
- Background Note
Note on Long-Term Care
Keywords: Health Care and Treatment
Herzlinger, Regina E. "Note on Long-Term Care." Harvard Business School Background Note 187-093, December 1986. (Revised November 1988.)
- September 2013
- Case
Boston Children's Hospital: Measuring Patient Costs (Abridged)
By: Robert S. Kaplan
The case describes a pilot project on applying activity-based costing to measure the cost of treating patients. After an overview of Boston Children's Hospital and its local health care market environment, the case presents process maps and financial data relating to... View Details
Keywords: Health Care; Time-Driven Activity-Based Costing; Costing; Hospitals; Activity Based Costing and Management
Kaplan, Robert S. "Boston Children's Hospital: Measuring Patient Costs (Abridged)." Harvard Business School Case 914-407, September 2013.
- October 20, 2021
- Other Article
On the Brink of a Digital Health Care Transformation: What Germany Can Learn from the United States
By: Yoni Goldwasser, William J. Gordon, Jan B. Brönneke and Ariel D. Stern
Goldwasser, Yoni, William J. Gordon, Jan B. Brönneke, and Ariel D. Stern. "On the Brink of a Digital Health Care Transformation: What Germany Can Learn from the United States." Health Affairs Blog (October 20, 2021).
- April 18, 2022
- Article
Will mRNA Technology Companies Spawn Innovation Ecosystems?
By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in... View Details
Keywords: Health Care; Digital Health; Technology; Innovation; Health Care and Treatment; Technological Innovation; Digital Transformation; Health Industry; United States
Grimpe, Christoph, Timo Minssen, W. Nicholson Price, II, and Ariel Dora Stern. "Will mRNA Technology Companies Spawn Innovation Ecosystems?" Harvard Business Review (website) (April 18, 2022).
- 07 Jan 2016
- News
Mass. Launches Partnership Aimed At Boosting Digital Health Sector
- November 2008 (Revised October 2009)
- Case
American Cancer Society: Access to Care
By: Robert L. Simons and Kathryn Rosenberg
CEO John Seffrin decides to radically change the strategy of the American Cancer Society. The new Access to Care strategy relies on advocacy to change public policy and increase the number of Americans eligible for cancer prevention and treatment. The new strategy... View Details
Keywords: Values and Beliefs; Governance Controls; Leading Change; Organizational Change and Adaptation; Organizational Structure; Nonprofit Organizations; Business Strategy; Health Industry; United States
Simons, Robert L., and Kathryn Rosenberg. "American Cancer Society: Access to Care." Harvard Business School Case 109-015, November 2008. (Revised October 2009.)
- July 1991 (Revised July 1993)
- Case
Alliant Health System: A Vision of Total Quality
Alliant has been a leader in the health care industry in implementing total quality management. After five years, however, they do not have much to show for their efforts except a "foundation" of quality attitudes and processes. The case discusses their plans to "jump... View Details
Keywords: Quality; Management Practices and Processes; Information Technology; Health Care and Treatment; Health Industry
Linder, Jane C. "Alliant Health System: A Vision of Total Quality." Harvard Business School Case 192-003, July 1991. (Revised July 1993.)
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS... View Details
- October 1999 (Revised November 1999)
- Case
VITAS: Innovative Hospice Care
VITAS, a for-profit hospice, has grown through acquisitions and start-ups. The company considers a rollup strategy, and Deirdre Lawe must decide whether to make a particular acquisition. View Details
Keywords: Value Creation; For-Profit Firms; Service Delivery; Health Care and Treatment; Acquisition; Service Industry
Hallowell, Roger H., and Tonicia C. Hampton. "VITAS: Innovative Hospice Care." Harvard Business School Case 800-031, October 1999. (Revised November 1999.)
- 26 May 2020
- News
The Five Deadly Sins Of Private Health Insurance
- October 2023
- Article
Clinician Response to Patient Medication Prices Displayed in the Electronic Health Record
By: Anna D Sinaiko, Caroline E Sloan, Mark J Soto, Olivia Zhao, Chen-Tan Lin and Foster R Goss
Keywords: Prescription Drugs; Electronic Health Records; Physicians; Prescription Drug Costs; Health Care and Treatment; Price; Health Industry
Sinaiko, Anna D., Caroline E Sloan, Mark J Soto, Olivia Zhao, Chen-Tan Lin, and Foster R Goss. "Clinician Response to Patient Medication Prices Displayed in the Electronic Health Record." JAMA Internal Medicine 183, no. 10 (October 2023): 1172–1175.
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
- June 2011 (Revised August 2011)
- Case
Colgate-Palmolive: Staying Ahead in Oral Care
By: Rebecca M. Henderson and Ryan Johnson
In 2011, Colgate-Palmolive (Colgate) was the global leader in oral care, with a dominant market share lead in toothpaste and a growing presence in toothbrushes and mouthwash. However, the firm faced stiff competition with perennial rivals P&G increasing their focus on... View Details
Keywords: Innovation Strategy; Brands and Branding; Product Positioning; Distribution Channels; Relationships; Competition; Competitive Advantage; Customization and Personalization; Health Industry
Henderson, Rebecca M., and Ryan Johnson. "Colgate-Palmolive: Staying Ahead in Oral Care." Harvard Business School Case 311-120, June 2011. (Revised August 2011.)
- 15 Jul 2020
- Video
The HBS Health Minute: A Tool Kit for Entrepreneurs
- August 2014
- Case
Blue Cross Blue Shield of Florida, Inc.
By: Regina E. Herzlinger and Meng Li
Keywords: Health; Health Care Industry; Health Insurance; United States; Health Care and Treatment; Health Industry; United States; Florida
Herzlinger, Regina E., and Meng Li. "Blue Cross Blue Shield of Florida, Inc." Harvard Business School Case 315-009, August 2014.
- 13 Dec 2006
- Research & Ideas
Improving Public Health for the Poor
School of Public Health, Project Antares aims to create a system for devising commercial incentives that provide affordable public health initiatives, or "interventions" in healthcare parlance. Examples of commercial high-impact... View Details
- August 2001 (Revised March 2008)
- Case
Helios Health (A)
By: Regina E. Herzlinger and Alfred Martin
Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details
Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Health Industry; Health Industry
Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
- 22 Apr 2009
- Other Presentation
Redefining Global Health Care: Narrowing the Gap Between Aspiration and Action
By: Michael E. Porter and Jim Yong Kim
Gaps in health financing, human resources, and access to care have fatal consequences for millions in developing countries. View Details
Porter, Michael E., and Jim Yong Kim. "Redefining Global Health Care: Narrowing the Gap Between Aspiration and Action." Global Health Delivery Case Discussion, Global Health Delivery Project at Harvard University, Boston, MA, April 22, 2009.